MedTrace Logo

CytoQuel: Clinical Documentation on Effects on Chronic Pain, Wellness, and Reduction of Inflammatory Markers

NCT03690609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2020-02-12

No results posted yet for this study

Summary

The purpose for this protocol is to perform an open-label parallel-arm clinical study in healthy subjects to evaluate the efficacy of a nutraceutical product on chronic pain, vascular health, inflammation, and overall wellness.

Conditions

Interventions

DIETARY_SUPPLEMENT

CytoQuel

3 capsules daily.

DIETARY_SUPPLEMENT

CytoQuel

2 capsules twice daily.

Sponsors & Collaborators

  • Natural Immune Systems Inc

    lead OTHER

Principal Investigators

  • Gitte Jensen · NIS Labs

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-21
Primary Completion
2017-12-15
Completion
2018-01-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03690609 on ClinicalTrials.gov